Additional European Equity News

Air France (AF FP) - Q4 2025 (EUR): Revenue 8.19bln (exp. 8.1bln), Op. Result 393mln, -10% Y/Y. Group Passengers 24.6mln, +4.8% Y/Y. CEO: “Despite ongoing external uncertainty, we approach 2026 with confidence and a commitment to executing our strategic roadmap with rigor and discipline in order to reach our medium-term goals”. FY Outlook: Expects capacity up by +3-5% compared to 2025. (Air France) 

Astrazeneca (AZN LN) - Co’s ENHERTU type II variation application validated in the EU as post-neoadjuvant treatment for patients with HER2 positive early breast cancer. Phase 3 trial results showed ENHERTU reduced the risk of invasive disease recurrence or death by 53% compared to T-DM. If approved, Daiichi Sankyo and AstraZeneca’s ENHERTU has the potential to become a new standard of care in this early breast cancer setting. (Businesswires)   

BE Semiconductor (BESI NA) - Q4 2025 (EUR): Revenue 166.4mln (exp. 163.3mln), Net income 42.8mln (prev. 25.3mln Y/Y), EPS (basic) 0.54 (prev. 0.32 Y/Y). (BE Semiconductor)   

Centrica (CEN LN) - FY 2025 (GBP): Revenue 22.4bln (prev. 24.6bln Y/Y), Adj. Operational income 814mln (prev. 1.55bln Y/Y), EPS 11.2p (prev. 19p Y/Y); guides initial FY26 retail EBITDA between GBP 500-800mln and Capex at 700mln. (Centrica)

Debenham (DEB LN) - Co. raises GBP 40mln in share placement.   

Drax Group (DRX LN) - Co. signs a 15 year tolling agreement with no indexations; projection grid connections, targeting a commercial operation date. (Drax Group)  

Nationwide Building Society (NBS LN) - PriceHubble outlines that UK banks, with Nationwide one to watch, face increasing scrutiny over the potential underestimation of flood risk in mortgage portfolios. (Bloomberg)

Nexans (NEX FP) - FY 2025 (EUR): Revenue 7.81bln (exp. 7.19bln), Net income 219mln (prev. 167mln Y/Y), Adj. EBITDA 728mln (prev. 571mln Y/Y), dividend per share 2.9 (prev. 2.6 Y/Y). (Nexans) 

Repsol (REP SM) - Q4 2025 (EUR): Net income 722mln (prev. 574mln Y/Y), EPS 0.64 (exp. 0.49, prev. 0.49 Y/Y). (Repsol)

Phosphorus, Herbicides - President Trump signed an executive order invoking the Defense Production Act to protect US domestic supplies of elemental phosphorus and glyphosate-based herbicides. Elemental phosphorus is used by the military and processed into white phosphorus for munitions or agricultural applications.

SAP (SAP GY) - Co. raises its annual dividend to EUR 2.50/shr (prev. EUR 2.35/shr), +6.4% Y/Y. (SAP)

Volkswagen (VOW3 GY) - WiWo writes that insiders report on risky accounting manipulation, and EUR 6bln has suddenly appeared at the Co. The article adds that insiders see dangerous "sleight of hand" involving Luxembourg holding firms. (WiWo)

Watches of Switzerland (WOSG LN) / Richemont (CFR FP) / Swatch Group (UHR SW) - Swiss Watch Exports -3.6% (Prev. +3.3%) 

Zealand Pharma (ZEAL DC) - FY 2025 (DKK): Revenue 9.22bln (exp. 9dangerous.23bln), Operating result 6.96bln (prev. -1.27bln Y/Y), Total earnings/(loss) per share, basic 91.56 (prev. -16.24). (Zealand Pharma)

Swedish Orphan Biovitrum (SOBI SS) downgraded to Hold from Buy at Danske Bank

19 Feb 2026 - 07:04- EquitiesEU Research- Source: Newsquawk